Skip to content
healthcare.dev
Get a free key

PERJETA

NDC 50242-145, Pertuzumab, injection, solution, concentrate, from Genentech, Inc..

Product NDC
50242-145
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125409
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PERTUZUMAB30 mg/mL

Pharmacologic classes

HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]

Package NDCNDC-11Package
50242-145-01502420145011 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/17f85d17-ab71-4f5b-9fe3-0b8c822f69ff

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-145

Use it

Look up 50242-145 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.